|
|
Volumn 294, Issue 5548, 2001, Pages 1813-1814
|
|
A 'sure killer' yields to medicine
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAGNOSIS;
DRUG PRODUCTS;
VIRUSES;
DRUG INHALATION;
MEDICINE;
DISEASE;
DRUG DEVELOPMENT;
ANTHRAX;
BACILLUS ANTHRACIS;
BIOLOGICAL WARFARE;
DATA ANALYSIS;
DISEASE COURSE;
EPIDEMIC;
HUMAN;
PLAGUE;
PRIORITY JOURNAL;
PROGNOSIS;
SHORT SURVEY;
SPOROGENESIS;
SURVIVAL;
ADULT;
ARTICLE;
CHILD;
DISEASE PREDISPOSITION;
DRUG COMBINATION;
FEMALE;
HISTORY;
HISTORY OF MEDICINE;
MALE;
MICROBIOLOGY;
PATHOGENICITY;
PHYSIOLOGY;
PLEURA EFFUSION;
RUSSIAN FEDERATION;
UNITED STATES;
CIPROFLOXACIN;
CLINDAMYCIN;
RIFAMPICIN;
ADULT;
ANTHRAX;
BACILLUS ANTHRACIS;
CHILD;
CIPROFLOXACIN;
CLINDAMYCIN;
DISEASE SUSCEPTIBILITY;
DRUG THERAPY, COMBINATION;
FEMALE;
HISTORY OF MEDICINE, 20TH CENT.;
HISTORY OF MEDICINE, 21ST CENT.;
HUMAN;
MALE;
PLEURAL EFFUSION;
PROGNOSIS;
RIFAMPIN;
RUSSIA;
UNITED STATES;
|
|
EID: 0035976943
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.294.5548.1813 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|